Association analysis between hyperuricemia and long term mortality after acute coronary syndrome in three subgroups...

Area of Science:

• Cardiology
• Clinical Research
• Biochemistry

Background:

• Acute coronary syndrome (ACS) is a leading cause of mortality worldwide.
• Identifying prognostic factors for long-term outcomes after ACS is critical for patient management.
• Hyperuricemia, elevated uric acid levels, is increasingly recognized as a potential risk factor in cardiovascular disease.

Purpose of the Study:

• To investigate the prognostic significance of hyperuricemia in patients following acute coronary syndrome.
• To analyze the association between hyperuricemia and long-term mortality.
• To stratify the prognostic impact of hyperuricemia based on the presence of comorbidities like diabetes, hypertension, and kidney failure.

Main Methods:

• Retrospective analysis of patient data collected between 2008 and 2013.
• Inclusion of patients admitted for acute coronary syndrome.
• Multivariate analysis to assess variables associated with long-term mortality, with stratification by key comorbidities.

Main Results:

• Hyperuricemia was identified as a significant prognostic factor for long-term mortality after acute coronary syndrome.
• The predictive value of hyperuricemia was further evaluated in subgroups of patients with diabetes, hypertension, or kidney failure.
• Detailed multivariate analysis results linking hyperuricemia to mortality outcomes are presented.

Conclusions:

• Hyperuricemia serves as an important prognostic indicator for long-term mortality in the context of acute coronary syndrome.
• The study highlights the need to consider uric acid levels in risk stratification protocols for ACS patients.
• Understanding the interplay between hyperuricemia and common comorbidities can refine cardiovascular risk assessment.